WPI 1118 Pill — YELLOW OVAL, 13mm — Mirtazapine

No photo available

Imprint	WPI / 1118
Colour	YELLOW
Shape	OVAL
Size	13
Strength	MIRTAZAPINE 30 mg
Dosage form	Tablet, Film Coated
Manufacturer	Aidarex Pharmaceuticals LLC
NDC	33261-074
Schedule	—
Availability	—
Ingredients	MIRTAZAPINE[MIRTAZAPINE]

What does this imprint mean?

The imprint "WPI 1118" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Mirtazapine

Uses and warnings

BOXED WARNING: "Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults," and prescribers are instructed to "balance this risk with the clinical need," with close monitoring advised, especially early in treatment and after dose changes. Concomitant use with a monoamine oxidase inhibitor "is contraindicated," as is starting mirtazapine within 14 days of stopping an MAOI. Other major warnings include agranulocytosis/severe neutropenia, serotonin syndrome risk with other serotonergic or dopaminergic drugs, activation of mania/hypomania, seizures, and hyponatremia.

"REMERON (mirtazapine) Tablets are indicated for the treatment of major depressive disorder," with efficacy established in placebo-controlled trials of outpatients meeting DSM criteria for a major depressive episode.

Read the full drug profile →